Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Sep;4(3):366-71.
doi: 10.1128/AAC.4.3.366.

Pharmacodynamics of cefazolin in the presence of normal and impaired renal function

Pharmacodynamics of cefazolin in the presence of normal and impaired renal function

M F Rein et al. Antimicrob Agents Chemother. 1973 Sep.

Abstract

The excretion of cefazolin, a new cephalosporin antibiotic, was studied in subjects with normal and impaired renal function. Twelve subjects with creatinine clearances ranging from 0 to 144 ml per min per 1.73 m(2) were given a single 500-mg intramuscular dose of cefazolin. Serum and urine levels were determined at intervals by agar diffusion. Peak serum levels in normals ranged from 44 to 70 mug/ml and occurred 30 to 60 min after injection. The mean serum half-life in normals was 1.6 h, and this was prolonged from 20 to 40% by simultaneous administration of probenecid. The total elimination constant varied linearly with the creatinine clearance in patients with renal impairment. The serum half-life in anephric patients was about 42 h. The fractional clearance of the drug varied directly with the serum level. Peak urine levels ranged from 60 to over 2,000 mug/ml, and more than 90% of the dose was recovered in the urine of normals during the first 24 h. The data suggest that cefazolin is cleared primarily by the glomerulus, with tubular and biliary secretion playing a secondary role.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Appl Microbiol. 1966 Mar;14(2):170-7 - PubMed
    1. Antimicrob Agents Chemother (Bethesda). 1966;6:101-6 - PubMed
    1. Clin Pharmacol Ther. 1968 May-Jun;9(3):345-9 - PubMed
    1. J Antibiot (Tokyo). 1970 Apr;23(4):184-94 - PubMed
    1. J Antibiot (Tokyo). 1970 Mar;23(3):131-6 - PubMed

LinkOut - more resources